Abstract
Rapid advances in genetic testing have improved the probability of successful genetic diagnosis. For couples who undergo a termination of pregnancy (TOP) due to foetal congenital malformations, these techniques may reveal the underlying cause and satisfy parents’ need to know. The aim of this qualitative descriptive research study was to explore couples’ experience of being recontacted after a congenital malformation-related TOP, as well as their reasons for participation. A retrospective cohort of 31 eligible candidates was recontacted for additional genetic testing using a standardized letter followed by a telephone call. Fourteen participants (45%) were included. Data were collected through semi-structured interviews at a hospital genetics department (UZ Brussel). Interviews were audiotaped, transcribed and analysed using thematic analysis. We found that despite the sometimes considerable length of time that passed since TOP, participants were still interested in new genetic testing. They appreciated that the initiative originated from the medical team, describing it as a “sensitive” approach. Both intrinsic (providing answers for themselves and their children) and extrinsic motivators (contributing to science and helping other parents) were identified as important factors for participation. These results show that participants often remain interested in being recontacted for new genetic testing such as whole genome sequencing, even after several years. As such, the results of this study can offer guidance in the more general current debate on recontacting patients in the field of genetics.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others
Data availability
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
References
Lord J, McMullan DJ, Eberhardt RY, Rinck G, Hamilton SJ, Quinlan-Jones E. et al. Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study. Lancet [Internet]. 2019;393:747–57. https://doi.org/10.1016/S0140-6736(18)31940-8.
Vanakker O, Vilain C, Janssens K, Van der Aa N, Smits G, Bandelier C. et al. Implementation of genomic arrays in prenatal diagnosis: the Belgian approach to meet the challenges. Eur J Med Genet [Internet]. 2014;57:151–6. https://doi.org/10.1016/j.ejmg.2014.02.002.
Muys J, Blaumeiser B, Jacquemyn Y, Bandelier C, Brison N, Bulk S, et al. The Belgian MicroArray Prenatal (BEMAPRE) database: A systematic nationwide repository of fetal genomic aberrations. Prenat Diagn [Internet]. 2018 ;38:1120–8. https://onlinelibrary.wiley.com/doi/full/10.1002/pd.5373.
Tolusso LK, Hazelton P, Wong B, Swarr DT. Beyond diagnostic yield: prenatal exome sequencing results in maternal, neonatal, and familial clinical management changes. Genet Med [Internet]. 2021;23:909–17.
Montaguti E, Balducci A, Perolo A, Livi A, Contro E, Casadio P, et al. Prenatal diagnosis of congenital heart defects and voluntary termination of pregnancy. Am J Obstet Gynecol MFM [Internet]. 2020;2. https://doi.org/10.1016/j.ajogmf.2020.100207.
Lafarge C, Rosman S, Ville I. Pregnancy termination for fetal abnormality: Ambivalence at the heart of women’s experience. Women’s Stud Int Forum [Internet]. 2019 ;74:42–51. https://doi.org/10.1016/j.wsif.2019.02.007.
European Abortion Laws. A comparative overview. Cent Reprod Rights [Internet]. 2019 https://reproductiverights.org/sites/default/files/documents/European.
Lafarge C, Mitchell K, Fox P. Reproductive health matters an international journal on sexual and reproductive health and rights termination of pregnancy for fetal abnormality: a meta-ethnography of women’s experiences. Reprod Health Matters [Internet]. 2014;22:191–201. https://www.tandfonline.com/action/journalInformation?journalCode=zrhm21.
Sandelowski M, Barroso J. The travesty of choosing after positive prenatal diagnosis. J Obstet Gynecol Neonatal Nurs [Internet]. 2005 ;34:307–18. https://doi.org/10.1177/0884217505276291.
Rillstone P, Hutchinson SA. Pregnancy after a loss due to anomalies. J Obstet Gynecol Neonatal Nurs [Internet]. 2001;30:291–8. https://doi.org/10.1177/088421701129004139.
Plantinga M, Zwienenberg L, van Dijk E, Breet H, Diphoorn J, El Mecky J, et al. Parental experiences of rapid exome sequencing in cases with major ultrasound anomalies during pregnancy. Prenat Diagn [Internet]. 2022;42:762–74. https://onlinelibrary.wiley.com/doi/full/10.1002/pd.6056.
Carrieri D, Howard HC, Benjamin C, Clarke AJ, Dheensa S, Doheny S, et al. Recontacting patients in clinical genetics services: recommendations of the European society of human genetics. Eur J Hum Genet [Internet]. 2019 ;27:169–82. https://doi.org/10.1038/s41431-018-0285-1.
Sirchia F, Carrieri D, Dheensa S, Benjamin C, Kayserili H, Cordier C, et al. Recontacting or not recontacting? A survey of current practices in clinical genetics centres in Europe. Eur J Hum Genet [Internet]. 2018;26:946–54. https://doi.org/10.1038/s41431-018-0131-5.
Hunter A, Sharpe NF, Mullen, Meschino W. Ethical, legal, and practical concerns about recontacting patients to inform them of new information: the case in medical genetics. Am J Med Genet. 2001;265–76. https://pubmed.ncbi.nlm.nih.gov/11746004/.
Fitzpatrick JL, Hahn C, Costa T, Huggins MJ. The duty to recontact: attittudes of genetics service providers. Am J Hum Genet [Internet]. 1999;64:852–60. https://doi.org/10.1086/302293.
Giesbertz NAA, van Harten WH, Bredenoord AL. A duty to recontact in genetics: context matters. Nat Rev Genet 2019 207 [Internet]. 2019 ;20:371–2. https://www.nature.com/articles/s41576-019-0121-7.
Otten E, Plantinga M, Birnie E, Verkerk MA, Lucassen AM, Ranchor AV, et al. Is there a duty to recontact in light of new genetic technologies? A systematic review of the literature. Genet Med [Internet]. 2015;17:668–78. https://doi.org/10.1038/gim.2014.173.
Beunders G, Dekker M, Haver O, Meijers-Heijboer HJ, Henneman L. Recontacting in light of new genetic diagnostic techniques for patients with intellectual disability: Feasibility and parental perspectives. Eur J Med Genet [Internet]. 2018 ;61:213–8. https://doi.org/10.1016/j.ejmg.2017.11.017.
Sexton AC, Sahhar M, Thorburn DR, Metcalfe SA. Impact of a genetic diagnosis of a mitochondrial disorder 5–17 years after the death of an affected child. J Genet Couns [Internet]. 2008;17:261–73. http://doi.wiley.com/10.1007/s10897-007-9145-9.
Velthuizen ME, van der Luijt RB, de Vries BJ, Koudijs MJ, Bleiker EMA, Ausems MGEM. Recontacting non-BRCA1/2 breast cancer patients for germline CHEK2 c.1100del pathogenic variant testing: uptake and patient experiences. Hered Cancer Clin Pr [Internet]. 2021;19:1–9. https://hccpjournal.biomedcentral.com/articles/10.1186/s13053-021-00166-1.
Carrieri D, Dheensa S, Doheny S, Clarke AJ, Turnpenny PD, Lucassen AM, et al. Recontacting in clinical practice: The views and expectations of patients in the United Kingdom. Eur J Hum Genet [Internet]. 2017;25:1106–12. www.nature.com/ejhg.
Dheensa S, Carrieri D, Kelly S, Clarke A, Doheny S, Turnpenny P, et al. A “joint venture” model of recontacting in clinical genomics: challenges for responsible implementation. Eur J Med Genet. 2017;60:403–9.
Dufrasne S, Roy M, Galvez M, Rosenblatt DS. Experience over fifteen years with a protocol for predictive testing for Huntington disease. Mol Genet Metab [Internet]. 2011;102:494–504. https://doi.org/10.1016/j.ymgme.2010.12.001.
Clark S, Bluman LG, Borstelmann N, Regan K, Winer EP, Rimer BK, et al. Patient motivation, satisfaction, and coping in genetic counseling and testing for BRCA1 and BRCA2. J Genet Couns. 1999;9. https://doi.org/10.1023/A:1009463905057.
Erskine KE, Hidayatallah NZ, Walsh CA, Mcdonald TV, Cohen L, Marion RW, et al. Motivation to Pursue Genetic Testing in Individuals with a Personal or Family History of Cardiac Events or Sudden Cardiac Death. J Genet Couns [Internet]. 2014;23:849–59. https://doi.org/10.1007/s10897-014-9707-6.
Caelli K, Ray L, Mill J. ‘Clear as Mud’: toward greater clarity in generic qualitative research. [Internet]. 2016;2:1–13. https://journals.sagepub.com/doi/10.1177/160940690300200201.
Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol [Internet] 2006;3:77–101. https://doi.org/10.1191/1478088706qp063oa.
Rosenthal ET, Biesecker LG, Biesecker BB. Parental attitudes toward a diagnosis in children with unidenti®ed multiple congenital anomaly syndromes [Internet]. Am J Med Genet. 2001;103. https://doi.org/10.1002/ajmg.1527.
Fraiman YS, Wojcik MH. The influence of social determinants of health on the genetic diagnostic odyssey: who remains undiagnosed, why, and to what effect? Pediatr Res [Internet]. 2021. https://doi.org/10.1038/s41390-020-01151-5.
Spillmann RC, McConkie-Rosell A, Pena L, Jiang YH, Schoch K, Walley N, et al. A window into living with an undiagnosed disease: illness narratives from the undiagnosed diseases network. Orphanet J Rare Dis [Internet]. 2017;12. https://doi.org/10.1186/s13023-017-0623-3.
Mcconkie-Rosell A, Hooper SR, Pena LDM, Schoch K, Spillmann RC, Jiang Y-H, et al. Psychosocial profiles of parents of children with undiagnosed diseases: managing well or just managing? J Genet Couns [Internet]. 2018;27:935–46. https://doi.org/10.1007/s10897-017-0193-5.
Acknowledgements
The authors would like to thank the study participants, we appreciate their willingness to share their experiences with us. Furthermore we thank the teams of Medical Genetics and Prenatal Ultrasound of the UZ Brussel. Special thanks to Chris Winter and Florence Belva for their critical revisions during the writing of this manuscript.
Funding
This study is part of the Igencare study financed by INNOVIRIS (Brussels institution for research and development). The funders had no role in the design, analysis or writing of this article.
Author information
Authors and Affiliations
Contributions
All authors contributed to the manuscript, all authors read and approved the final manuscript. IS was responsible for designing and writing the study protocol, data collection, analysing the data, interpreting the results and writing the manuscript. KVB assisted with data collection. RC played an important role in interpreting the data and revising the results. KK, FH and SVD revised the manuscript. MF supervised the methods, data interpretation and revision of the manuscript. SVD, FH, KK and IS designed the Igencare study.
Corresponding author
Ethics declarations
Ethics approval
The ethical committee of the UZ Brussel approved this study (B.U.N.143201838127).
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Slegers, I., Keymolen, K., Van Berkel, K. et al. Searching for a sense of closure: parental experiences of recontacting after a terminated pregnancy for congenital malformations. Eur J Hum Genet 32, 673–680 (2024). https://doi.org/10.1038/s41431-023-01375-z
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41431-023-01375-z
This article is cited by
-
Beyond the Diagnosis: Valuing Genome-Wide Sequencing for Rare Disease Diagnosis Using Contingent Valuation
Applied Health Economics and Health Policy (2025)
-
What’s new in EJHG in June 2024?
European Journal of Human Genetics (2024)

